OTTAWA, CANADA -- (MARKET WIRE) -- January 12, 2007 -- Chemaphor Inc. (TSX VENTURE: CFR) a biotechnology research and development company announced today that it plans to offer through a private placement up to 3,333,333 units at a price of $0.30 per unit. Each unit will consist of one common share and one warrant. Each warrant will entitle the holder to acquire one common share of Chemaphor at an additional purchase price of $0.40 per share at any time up to twenty-four months from the closing date.
